PDGFRA
Showing 1 - 25 of 102
Unresectable or Recurrent Metastatic GIST Non-exon18 Mutations
Not yet recruiting
- Gastrointestinal Stromal Tumors
- +2 more
- (no location specified)
Jul 15, 2022
Solid Tumor, Unspecified, Child, Relapsed Solid Tumor, CNS Tumor Trial in Worldwide (avapritinib)
Recruiting
- Solid Tumor, Unspecified, Child
- +2 more
-
Phoenix, Arizona
- +12 more
Jul 19, 2022
GIST, GIST, Malignant, PDGFR-Alpha D842V Trial in France (Patient treated by Avapritinib in real life)
Recruiting
- GIST
- +2 more
- Patient treated by Avapritinib in real life
-
Besançon, France
- +5 more
Jun 9, 2021
Recurrent/Refractory Glioblastoma Trial in Houston (crenolanib)
Completed
- Recurrent/Refractory Glioblastoma
-
Houston, TexasMD Anderson Cancer Center
Jul 17, 2020
FLT3-ITD Mutation, FLT3/TKD Mutation, PDGFR-Alpha D842V Trial in Genova (Crenolanib besylate)
Available
- FLT3-ITD Mutation
- +3 more
- Crenolanib besylate
-
Genova, ItalyOspedale Policlinico San Martino
May 21, 2020
GIST With D842V Mutated PDGFRA Gene Trial in Worldwide (Crenolanib, Placebo)
Active, not recruiting
- GIST With D842V Mutated PDGFRA Gene
- Crenolanib
- Placebo
-
Santa Monica, California
- +22 more
Jan 21, 2021
Oncogenetic Panel and Integrated Clinical Data Registry Study
Recruiting
- Gastrointestinal Stromal Tumor (GIST)
-
Changhua, Taiwan
- +12 more
Dec 6, 2022
Meta-analysis of Metatrascryptome and Transcriptome of
Not yet recruiting
- Eosinophilic Esophagitis
- Formalin-fixed Paraffin-embedded (FFPE) tissue samples analysis
-
Milan, ItalyIRCCS Ospedale San Raffaele
Oct 2, 2023
Malignant Tumor Trial in Ann Arbor, Columbus (ponatinib HCl, laboratory biomarker analysis)
Unknown status
- Malignant Neoplasm
- ponatinib hydrochloride
- laboratory biomarker analysis
-
Ann Arbor, Michigan
- +1 more
Feb 14, 2020
Avapritinib in Chinese Gastrointestinal Stromal Tumor in Real
Recruiting
- Gastrointestinal Stromal Tumors
- Avapritinib
- Tyrosine kinase inhibitors other than avapritinib ( imatinib, sunitinib, et al )
-
Beijing, Beijing, ChinaBeijing Cancer Hospital
Sep 14, 2022
Core Binding Factor Acute Myeloid Leukemia, KIT Mutation-Related Tumors Trial in Suzhou (Avapritinib)
Recruiting
- Core Binding Factor Acute Myeloid Leukemia
- KIT Mutation-Related Tumors
-
Suzhou, Jiangsu, ChinaFirst Affiliated Hospital of Soochow University
Apr 7, 2023
Metastatic or Unresectable Gastrointestinal Stromal Tumors
Not yet recruiting
- Gastrointestinal Stromal Tumors
- +2 more
- (no location specified)
Jul 16, 2022
Surgery in Gastrointestinal Stromal Tumors for Treatment, Tumor
Recruiting
- Gastric Cancer
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 30, 2023
Gastrointestinal Stromal Tumor (GIST) Trial in Guayaquil (Endoscopic ultrasound guided radiofrequency ablation)
Recruiting
- Gastrointestinal Stromal Tumor (GIST)
- Endoscopic ultrasound guided radiofrequency ablation
-
Guayaquil, Guayas, EcuadorInstituto Ecuatoriano de Enfermedades Digestivas (IECED)
Aug 8, 2022
Glioblastoma, Recurrent Adult Brain Tumor, Malignant Glioma Trial in Richmond (sorafenib tosylate, valproic acid, sildenafil
Active, not recruiting
- Glioblastoma
- +3 more
- sorafenib tosylate
- +2 more
-
Richmond, VirginiaVirginia Commonwealth University/Massey Cancer Center
Mar 21, 2022
Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors Trial in Canada (Olaparib, Dasatinib, Nivolumab plus Ipilimumab)
Recruiting
- Lymphoma, Non-Hodgkin
- +2 more
- Olaparib
- +13 more
-
Edmonton, Alberta, Canada
- +9 more
Jan 9, 2023
Gastrointestinal Stromal Tumors Trial in Seoul (Temozolomide capsule)
Not yet recruiting
- Gastrointestinal Stromal Tumors
- Temozolomide capsule
-
Seoul, Korea, Republic ofAsan Medical Center, University of Ulsan College of Medicine
Dec 14, 2022
GIST: Assessment of Tumor Mutations and TKI Plasma Exposure
Recruiting
- Gastro-intestinal Stromal Tumor
- Vena puncture for blood collection
- Tumor biopsy
-
Amsterdam, Netherlands
- +4 more
May 17, 2022
Gastrointestinal Stromal Tumors (GIST), Other Relapsed or Refractory Solid Tumors Trial in Worldwide (Avapritinib)
Completed
- Gastrointestinal Stromal Tumors (GIST)
- Other Relapsed or Refractory Solid Tumors
-
Scottsdale, Arizona
- +18 more
May 20, 2022
ctDNA in Cancer Early Detection and STAS Evaluation in GGOs
Not yet recruiting
- Lung Cancer
- +2 more
- cf DNA and ct DNA
-
Roma, ItalyThoracic Surgery Unit, Sapienza University of Rome
Mar 31, 2022
Integrated Molecular Profiling in Advanced Cancers Trial
Active, not recruiting
- Breast Cancer
- +9 more
-
Toronto, Ontario, CanadaPrincess Margaret Hospital
Sep 26, 2022
Ripretinib Combined With Surgery in Advanced GIST That Have
Recruiting
- Gastrointestinal Stromal Tumor(GIST)
- Resection surgery of gastrointestinal stromal tumor
-
Chengdu, Sichuan, ChinaSichuan Provincial People's Hospital
Apr 25, 2022
Gastrointestinal Stromal Tumors Trial (Imatinib Mesylate)
Recruiting
- Gastrointestinal Stromal Tumors
- Imatinib Mesylate
-
Seoul, Korea, Republic ofAsan Medical Center, University of Ulsan College of Medicine
Dec 22, 2022
Malignant Solid Tumors Trial in France (Nilotinib (400 mg BID), Everolimus (10 mg QD), Sorafenib (400 mg BID))
Recruiting
- Malignant Solid Neoplasms
- Nilotinib (400 mg BID)
- +6 more
-
Bordeaux, France
- +6 more
Dec 15, 2022
Second-line Pharmacotherapy Patterns and Outcomes of Advanced
Not yet recruiting
- Gastrointestinal Stromal Tumors
-
Guangzhou, Guangdong, ChinaThe first affiliated hospital,Sun yat-sen university
Jun 30, 2022